XYL
Xylem Inc. NYSE Listed Oct 13, 2011$115.60
Mkt Cap $27.5B
52w Low $114.15
3.6% of range
52w High $154.27
50d MA $122.49
200d MA $136.47
P/E (TTM)
29.4x
EV/EBITDA
18.8x
P/B
2.4x
Debt/Equity
0.2x
ROE
8.9%
P/FCF
36.4x
RSI (14)
—
ATR (14)
—
Beta
1.17
50d MA
$122.49
200d MA
$136.47
Avg Volume
2.3M
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, Leopold, Wedeco, and Xylem Vue brand names for the transportation and treatment of water. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, Xylem Vue and Flojet brand names for residential and commercial building services, and industrial water applications. The Measurement & Control Solutions segment provides smart meters, networked communication devices, and measurement and control technologies, as well as critical infrastructure technologies. It also offers software and services, including cloud-based analytics, remote monitoring and data management, leak detection, condition assessment, asset management, and pressure monitoring solutions, as well as testing equipment and managed services. This segment sells its products under the Pure, Sensus, Smith Blair, WTW, Xylem Vue, and YSI brand names. The company markets and sells its products through a network of direct sales force, resellers, distributors, and value-added solution providers. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in May 2011. The company. was incorporated in 2011 and is headquartered in Rye Brook, New York.
301 Water Street SE · Washington, DC 20003 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | TNS | 1.09 | 1.12 | +2.8% | 117.91 | -0.1% | -2.1% | +0.2% | -2.2% | -2.6% | -0.9% | — |
| Feb 10, 2026 | TNS | 1.41 | 1.42 | +0.7% | 128.92 | +1.0% | -1.7% | -2.2% | -0.6% | -0.6% | +0.2% | — |
| Oct 28, 2025 | TNS | 1.23 | 1.37 | +11.4% | 150.50 | +1.0% | +1.6% | +0.7% | +0.2% | -0.9% | -0.5% | — |
| Jul 31, 2025 | TNS | 1.15 | 1.26 | +9.6% | 144.62 | -0.6% | -1.7% | -0.4% | -0.7% | -0.7% | -0.8% | — |
| Apr 29, 2025 | TNS | 0.95 | 1.03 | +7.9% | 118.62 | -0.5% | +1.6% | +1.8% | +4.7% | +3.1% | +1.5% | — |
| Feb 4, 2025 | TNS | 1.13 | 1.18 | +4.4% | 129.24 | -0.2% | +0.4% | +1.7% | +1.4% | +1.6% | +2.2% | — |
| Oct 31, 2024 | TNS | 1.11 | 1.11 | +0.0% | 121.78 | -0.3% | -1.9% | -0.8% | +0.4% | +1.6% | +1.5% | — |
| Jul 30, 2024 | TNS | 1.05 | 1.09 | +3.8% | 133.48 | +1.0% | +0.0% | -0.1% | -2.5% | -5.5% | -4.6% | — |
| May 2, 2024 | TNS | 0.84 | 0.90 | +7.3% | 135.99 | +1.1% | +0.9% | +2.4% | +3.0% | +3.8% | +4.9% | — |
| Feb 6, 2024 | TNS | 0.96 | 0.99 | +3.1% | 119.56 | +0.9% | +3.2% | +2.4% | +4.0% | +3.1% | +1.8% | — |
| Oct 31, 2023 | TNS | 0.89 | 0.99 | +11.2% | 93.54 | -0.3% | +1.0% | +0.8% | +3.6% | +2.8% | +3.5% | — |
| Aug 2, 2023 | TNS | 0.85 | 0.98 | +15.3% | 112.08 | -0.5% | -3.3% | -5.7% | -4.6% | -6.2% | -8.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Citigroup | Maintains | Buy → Buy | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | -2.6% | -1.3% |
| Apr 29 | Stifel | Maintains | Buy → Buy | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | -2.6% | -1.3% |
| Apr 29 | Barclays | Maintains | Overweight → Overweight | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | -2.6% | -1.3% |
| Apr 29 | Oppenheimer | Maintains | Outperform → Outperform | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | -2.6% | -1.3% |
| Apr 29 | UBS | Maintains | Neutral → Neutral | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | -2.6% | -1.3% |
| Apr 21 | UBS | Downgrade | Buy → Neutral | $132 | $120.46 | $118.67 | -1.5% | -0.4% | +0.8% | +1.0% | +0.8% | +2.5% |
| Apr 16 | JP Morgan | Maintains | Overweight → Overweight | — | $125.19 | $124.96 | -0.2% | +0.0% | -3.3% | -3.8% | -4.2% | -3.0% |
| Apr 14 | Stifel | Maintains | Buy → Buy | — | $128.85 | $128.88 | +0.0% | +0.6% | -2.8% | -2.8% | -6.0% | -6.5% |
| Apr 9 | UBS | Maintains | Buy → Buy | — | $127.97 | $127.16 | -0.6% | +1.1% | +0.6% | +0.7% | +1.3% | -2.2% |
| Apr 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $119.50 | $120.33 | +0.7% | +2.5% | +1.5% | +3.6% | +4.0% | +7.1% |
| Feb 11 | Stifel | Maintains | Buy → Buy | — | $128.92 | $130.16 | +1.0% | -1.7% | -2.2% | -0.6% | -0.6% | +0.2% |
| Feb 11 | Barclays | Maintains | Overweight → Overweight | — | $128.92 | $130.16 | +1.0% | -1.7% | -2.2% | -0.6% | -0.6% | +0.2% |
| Feb 11 | Citigroup | Maintains | Buy → Buy | — | $128.92 | $130.16 | +1.0% | -1.7% | -2.2% | -0.6% | -0.6% | +0.2% |
| Feb 11 | RBC Capital | Maintains | Outperform → Outperform | — | $128.92 | $130.16 | +1.0% | -1.7% | -2.2% | -0.6% | -0.6% | +0.2% |
| Jan 7 | Barclays | Maintains | Overweight → Overweight | — | $141.33 | $141.13 | -0.1% | -1.3% | -0.3% | -1.2% | -1.6% | -0.9% |
| Jan 5 | Mizuho | Maintains | Neutral → Neutral | — | $137.11 | $136.56 | -0.4% | +1.4% | +3.1% | +1.7% | +2.8% | +1.9% |
| Dec 5 | TD Cowen | Maintains | Hold → Hold | — | $140.87 | $140.90 | +0.0% | -1.3% | -1.8% | -2.8% | -1.7% | -0.6% |
| Nov 6 | UBS | Maintains | Buy → Buy | — | $150.68 | $151.07 | +0.3% | -0.2% | +0.4% | +0.2% | -0.6% | -0.5% |
| Oct 29 | Stifel | Maintains | Buy → Buy | — | $150.50 | $152.03 | +1.0% | +1.6% | +0.7% | +0.2% | -0.9% | -0.5% |
| Oct 29 | RBC Capital | Maintains | Outperform → Outperform | — | $150.50 | $152.03 | +1.0% | +1.6% | +0.7% | +0.2% | -0.9% | -0.5% |
| Oct 29 | Citigroup | Maintains | Buy → Buy | — | $150.50 | $152.03 | +1.0% | +1.6% | +0.7% | +0.2% | -0.9% | -0.5% |
| Oct 29 | Barclays | Maintains | Overweight → Overweight | — | $150.50 | $152.03 | +1.0% | +1.6% | +0.7% | +0.2% | -0.9% | -0.5% |
| Oct 9 | Citigroup | Maintains | Buy → Buy | — | $148.19 | $147.67 | -0.4% | -0.9% | -2.6% | -1.5% | -1.1% | -1.6% |
| Sep 12 | Mizuho | Maintains | Neutral → Neutral | — | $141.80 | $141.53 | -0.2% | -0.2% | -0.0% | -0.8% | -0.6% | +0.3% |
| Aug 26 | TD Cowen | Maintains | Hold → Hold | — | $142.67 | $142.56 | -0.1% | +0.5% | +1.4% | +0.9% | -0.8% | -1.6% |
| Aug 5 | UBS | Maintains | Buy → Buy | — | $143.97 | $145.00 | +0.7% | -0.3% | -0.2% | -0.3% | -0.9% | -0.8% |
| Aug 1 | Stifel | Maintains | Buy → Buy | — | $144.62 | $143.69 | -0.6% | -1.7% | -0.4% | -0.7% | -0.7% | -0.8% |
| Jul 21 | Stifel | Maintains | Buy → Buy | — | $132.71 | $133.54 | +0.6% | -0.6% | -1.3% | -0.7% | -1.1% | -0.1% |
| Jul 14 | Citigroup | Maintains | Buy → Buy | — | $130.95 | $130.53 | -0.3% | +0.0% | -1.0% | -0.4% | +1.2% | +1.3% |
| Apr 30 | RBC Capital | Maintains | Outperform → Outperform | — | $118.62 | $118.06 | -0.5% | +1.6% | +1.8% | +4.7% | +3.1% | +1.5% |
| Apr 30 | Baird | Maintains | Outperform → Outperform | — | $118.62 | $118.06 | -0.5% | +1.6% | +1.8% | +4.7% | +3.1% | +1.5% |
| Apr 30 | Stifel | Maintains | Buy → Buy | — | $118.62 | $118.06 | -0.5% | +1.6% | +1.8% | +4.7% | +3.1% | +1.5% |
| Apr 16 | Stifel | Maintains | Buy → Buy | — | $109.14 | $108.26 | -0.8% | +0.0% | +1.2% | -0.6% | +2.3% | +3.9% |
| Apr 14 | Citigroup | Maintains | Buy → Buy | — | $109.06 | $111.24 | +2.0% | +0.6% | +0.1% | +0.1% | +1.2% | -0.5% |
| Feb 5 | Baird | Maintains | Outperform → Outperform | — | $129.24 | $129.00 | -0.2% | +0.4% | +1.7% | +1.4% | +1.6% | +2.2% |
| Jan 24 | Stifel | Maintains | Buy → Buy | — | $121.58 | $121.78 | +0.2% | -0.0% | +0.5% | -0.2% | -0.3% | +0.2% |
| Jan 13 | Citigroup | Maintains | Buy → Buy | — | $114.02 | $113.54 | -0.4% | +1.4% | +1.2% | +1.8% | +4.3% | +4.9% |
| Dec 12 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $123.38 | $122.08 | -1.1% | -1.9% | -2.3% | -2.1% | -2.1% | -5.2% |
| Dec 11 | Stifel | Maintains | Buy → Buy | — | $128.57 | $129.37 | +0.6% | -4.0% | -5.8% | -6.2% | -6.1% | -6.1% |
| Dec 9 | Citigroup | Upgrade | Neutral → Buy | — | $126.37 | $127.59 | +1.0% | +2.4% | +1.7% | -2.4% | -4.2% | -4.6% |
| Nov 6 | TD Cowen | Maintains | Hold → Hold | — | $122.26 | $125.32 | +2.5% | +1.2% | +1.1% | +1.7% | +1.9% | +2.1% |
| Nov 1 | RBC Capital | Maintains | Outperform → Outperform | — | $121.78 | $121.44 | -0.3% | -1.9% | -0.8% | +0.4% | +1.6% | +1.5% |
| Nov 1 | Baird | Maintains | Outperform → Outperform | — | $121.78 | $121.44 | -0.3% | -1.9% | -0.8% | +0.4% | +1.6% | +1.5% |
| Sep 3 | TD Cowen | Downgrade | Buy → Hold | — | $137.53 | $134.13 | -2.5% | -5.0% | -6.1% | -6.9% | -7.9% | -6.0% |
| Jul 31 | Stifel | Maintains | Buy → Buy | — | $133.48 | $134.88 | +1.0% | +0.0% | -0.1% | -2.5% | -5.5% | -4.6% |
| Jul 31 | Baird | Maintains | Outperform → Outperform | — | $133.48 | $134.88 | +1.0% | +0.0% | -0.1% | -2.5% | -5.5% | -4.6% |
| Jul 31 | RBC Capital | Maintains | Outperform → Outperform | — | $133.48 | $134.88 | +1.0% | +0.0% | -0.1% | -2.5% | -5.5% | -4.6% |
| Jul 18 | Stifel | Maintains | Buy → Buy | — | $139.00 | $138.39 | -0.4% | -0.7% | -1.1% | +0.2% | +1.2% | -1.6% |
| Jun 6 | TD Cowen | Maintains | Buy → Buy | — | $139.67 | $139.22 | -0.3% | -2.0% | -1.7% | -0.3% | -0.8% | +0.7% |
| May 31 | Oppenheimer | Maintains | Outperform → Outperform | — | $139.40 | $139.71 | +0.2% | +1.2% | -0.6% | -1.6% | +0.2% | -1.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | McShane Geri-MichelleOff | SVP, CAO | Sell | 4,269 | $117.46 | $501K | 3,605 | — | — |
| May 4, 2026 | Peribere Jerome ADir | — | Buy | 1,210 | $116.61 | $141K | 27,209 | +1.35% | — |
8-K
Xylem Inc -- 8-K Filing
Xylem achieved $2.1 billion in first-quarter 2026 revenue, demonstrating operational strength in its global water solutions business.
Apr 28
8-K · 8.01
!! High
Xylem Inc -- 8-K 8.01: Material Event / Announcement
Xylem Inc received board authorization for a $1.5 billion share repurchase program with no expiration date, allowing management flexibility to return capital to shareholders through open market purchases.
Feb 25
8-K
Xylem Inc -- 8-K Filing
Xylem delivered 6% reported revenue growth to $9.0 billion and raised 2026 guidance to $9.1-$9.2 billion, signaling continued momentum despite moderating organic growth expectations.
Feb 10
Data updated apr 27, 2026 11:02am
· Source: massive.com